Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis

Toby M. Maher, Ulrich Costabel, Marilyn K. Glassberg, Yasuhiro Kondoh, Takashi Ogura, Mary Beth Scholand, David Kardatzke, Monet Howard, Julie Olsson, Margaret Neighbors, Paula Belloni, Jeffrey J. Swigris

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences